. Cardiomyocytes of Hand-GAL4 > UAS-TER94 RNAi (L1) and Hand-GAL4 > UAS-TER94 RNAi (L2) Drosophila contain reduced TER94 mRNA levels. ViewRNA FISH was used to quantify TER94 mRNA levels in fly hearts. As shown in Figure 3 , a large reduction in TER94/GAPDH mRNA signals was determined in Hand 4.2 -GAL4 > UAS-TER94 RNAi (L1) cardimoyocytes compared to Hand 4.2 -GAL4 x w 1118 controls (** p < 0.001, n = 7). Hand 4.2 -GAL4 > UAS-TER94 RNAi (L2) hearts had a similar reduction in TER94/GAPDH mRNA vs. Hand 4.2 -GAL4 x attP2 controls (*** p < 0.0001, n = 8). Significance was assessed via unpaired t-test. Figure S2 . Heart performance of wildtype flies following RU486 treatment post-cardiac development. Semi-automated optical heartbeat analysis was performed on w 1118 flies placed on food supplemented with vehicle (100% ethanol) or 100 μg/mL RU486 (dissolved in 100% ethanol) for three weeks. Flies fed RU486 displayed significantly longer myogenic heart periods. However, relative to flies on vehicle, no differences in systolic diameters, diastolic diameters, or fractional shortening were observed. Thus RU486 does not drastically alter heart performance in flies treated with the compound post-cardiac development. Significance was assessed via unpaired t-test, * p < 0.05; n = 15.
. Cardiomyocytes of Hand-GAL4 > UAS-TER94 RNAi (L1) and Hand-GAL4 > UAS-TER94 RNAi (L2) Drosophila contain reduced TER94 mRNA levels. ViewRNA FISH was used to quantify TER94 mRNA levels in fly hearts. As shown in Figure 3 , a large reduction in TER94/GAPDH mRNA signals was determined in Hand 4.2 -GAL4 > UAS-TER94 RNAi (L1) cardimoyocytes compared to Hand 4.2 -GAL4 x w 1118 controls (** p < 0.001, n = 7). Hand 4.2 -GAL4 > UAS-TER94 RNAi (L2) hearts had a similar reduction in TER94/GAPDH mRNA vs. Hand 4.2 -GAL4 x attP2 controls (*** p < 0.0001, n = 8). Significance was assessed via unpaired t-test. Figure S2 . Heart performance of wildtype flies following RU486 treatment post-cardiac development. Semi-automated optical heartbeat analysis was performed on w 1118 flies placed on food supplemented with vehicle (100% ethanol) or 100 μg/mL RU486 (dissolved in 100% ethanol) for three weeks. Flies fed RU486 displayed significantly longer myogenic heart periods. However, relative to flies on vehicle, no differences in systolic diameters, diastolic diameters, or fractional shortening were observed. Thus RU486 does not drastically alter heart performance in flies treated with the compound post-cardiac development. Significance was assessed via unpaired t-test, * p < 0.05; n = 15.
